Inventum.AI
Biotechnology Research • 
Abu Dhabi, United Arab Emirates • 1-10 Employees
Company overview
| Headquarters | Abu Dhabi, United Arab Emirates |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
Key Contacts at Inventum.AI
Ruslan Lukin
Co-Founder, Cso
Ramil Kuleev
Director, Ceo
About Inventum.AI
Inventum.AI represents a significant advancement in the discovery of new therapeutics, promising to enhance the efficiency and effectiveness of pharmaceutical research. By leveraging the combined strengths of its expert team and cutting-edge AI technology, the platform not only increases the accuracy of drug molecule design but also democratizes access to drug discovery. This opens the door for more organizations to participate in the development of novel treatments. Our mission is to develop novel molecules using end-to-end generative AI with a focus on protein-ligand interactions. These molecules will meet the criteria of medicinal chemists, with a high probability of passing clinical trials, ensuring maximum efficacy and safety for patients.
Inventum.AI revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Inventum.AI has 5 employees across 5 departments.
Departments
Number of employees
Funding Data
Inventum.AI has never raised funding before.
Inventum.AI Tech Stack
Discover the technologies and tools that power Inventum.AI's digital infrastructure, from frameworks to analytics platforms.
CDN
Miscellaneous
Programming languages
Miscellaneous
Miscellaneous
Analytics
JavaScript frameworks
Switzerland
United States
New Zealand
CanadaFrequently asked questions
4.8
40,000 users
